Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Patients With Segmental Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles

NCT05520125 is registered in ClinicalTrials.gov with Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus as lead sponsor.

NCT NCT05520125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05520125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Patients With Segmental Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles
Lead sponsor
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 1, 2022
Completion date
December 31, 2023
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

segmental fracture - bone loss